◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › B › BHC

Bausch Health Companies Inc (BHC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · DATA UPDATED 2026-09-05

Bausch Health Companies Inc (BHC) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Laval, Canada with about 20,300 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, BHC reported $10.3B in revenue and $157M in net income.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

Interactive charts & full statements → Open the BHC valuation workbench →

BHC Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$10.9B	$10.3B	$9.6B	$8.8B	$8.1B	$8.4B	$8.0B	$8.6B	$8.4B	$8.7B	$9.7B	$10.4B	$8.2B	$5.8B	$3.5B	$2.5B	$1.1B	$820M	$757M	$843M	$1.1B
Gross Profit	$7.8B	$7.3B	$6.8B	$6.2B	$5.8B	$6.0B	$5.8B	$6.3B	$6.0B	$6.2B	$7.1B	$8.0B	$6.0B	$4.2B	$2.6B	$1.7B	$740M	$495M	$560M	$619M	$847M
Gross Margin %	71.8%	70.7%	71.1%	70.8%	70.9%	71.6%	72.0%	72.7%	72.0%	70.8%	73.4%	76.6%	73.1%	73.5%	74.4%	70.5%	64.6%	60.4%	74.0%	73.5%	79.1%
Operating Income (EBIT)	$2.8B	$2.2B	$1.5B	$963M	$454M	$450M	$676M	($203M)	($2.4B)	$102M	($566M)	$1.5B	$2.0B	($410M)	$80M	$525M	($110M)	$181M	$196M	$188M	$454M
Operating Margin %	25.4%	21.3%	16.1%	11.0%	5.6%	5.3%	8.4%	-2.4%	-28.4%	1.2%	-5.9%	14.6%	24.4%	-7.1%	2.3%	21.3%	-9.6%	22.1%	25.9%	22.3%	42.4%
Net Income	($1.1B)	$157M	($46M)	($592M)	($225M)	($948M)	($559M)	($1.8B)	($4.1B)	$2.4B	($2.4B)	($269M)	$881M	($866M)	($116M)	$160M	($208M)	$176M	$200M	$196M	$210M
Net Margin %	-10.1%	1.5%	-0.5%	-6.8%	-2.8%	-11.2%	-7.0%	-20.7%	-49.5%	27.6%	-24.9%	-2.6%	10.7%	-15.0%	-3.3%	6.5%	-18.2%	21.5%	26.4%	23.2%	19.6%
EBITDA	$2.0B	$3.2B	$3.1B	$2.9B	$2.9B	$3.3B	$3.1B	$3.4B	$3.3B	$3.4B	$4.1B	$5.1B	$3.9B	$2.8B	$1.8B	$901M	$103M	$349M	$231M	$289M	$350M
Earnings Per Share (EPS)	$-2.96	$0.42	$-0.12	$-1.62	$-0.62	$-2.64	$-1.57	$-5.06	$-11.86	$6.83	$-6.94	$-0.77	$2.58	$-2.70	$-0.38	$0.49	$-1.06	$1.11	$1.25	$1.22	$1.31
Shares Outstanding (M)	378M	375M	368M	365M	362M	359M	355M	352M	350M	352M	347M	347M	342M	321M	305M	326M	196M	159M	160M	161M	160M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BHC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$2.9B	$2.5B	$2.8B	$2.7B	$2.5B	$2.3B	$2.6B	$2.5B
Gross Profit	$2.1B	$1.8B	$2.0B	$1.9B	$1.8B	$1.6B	$1.8B	$1.8B
Gross Margin %	72.9%	70.8%	71.5%	72.0%	69.8%	69.0%	71.6%	72.3%
Operating Income (EBIT)	$775M	$521M	$829M	$636M	$457M	$292M	$558M	$318M
Operating Margin %	27.2%	20.6%	29.6%	23.7%	18.1%	12.9%	21.8%	12.7%
Net Income	$258M	($1.4B)	($112M)	$179M	$148M	($58M)	$93M	($85M)
Net Margin %	9.0%	-56.4%	-4.0%	6.7%	5.9%	-2.6%	3.6%	-3.4%
EBITDA	$1.0B	($657M)	$743M	$936M	$912M	$588M	$901M	$866M
Earnings Per Share (EPS)	$0.68	$-3.82	$-0.30	$0.48	$0.40	$-0.16	$0.25	$-0.23
Shares Outstanding (M)	378M	373M	371M	376M	373M	370M	372M	368M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BHC Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.8B	$1.4B	$1.6B	$1.0B	($728M)	$1.4B	$1.1B	$1.5B	$1.5B	$2.3B	$2.1B	$2.2B	$2.3B	$1.0B	$657M	$676M	$263M	$361M	$204M	$341M	$522M
Capital Expenditures (CapEx)	$408M	$397M	$337M	$272M	$268M	$283M	$309M	$278M	$235M	$336M	$291M	$303M	$471M	$185M	$181M	$386M	$17M	$569M	$22M	$35M	$45M
Free Cash Flow (FCF)	$1.4B	$1.0B	$1.3B	$760M	($996M)	$1.1B	$802M	$1.2B	$1.3B	$2.0B	$1.8B	$1.9B	$1.8B	$857M	$475M	$291M	$246M	($208M)	$182M	$306M	$477M
FCF Margin %	12.8%	9.8%	13.1%	8.7%	-12.3%	13.6%	10.0%	14.2%	15.1%	22.4%	18.6%	18.2%	22.2%	14.9%	13.7%	11.8%	21.5%	-25.4%	24.1%	36.3%	44.6%
Dividends Paid	—	—	—	—	$31M	—	—	—	—	$18M	$9M	$17.9B	$8M	$8.5B	$0M	$52M	$356M	$147M	$180M	$322M	$80M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BHC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$670M	$230M	$496M	$405M	$289M	$211M	$601M	$404M
Capital Expenditures (CapEx)	$77M	$147M	$93M	$91M	$99M	$124M	$107M	$71M
Free Cash Flow (FCF)	$593M	$83M	$403M	$314M	$190M	$87M	$494M	$332M
FCF Margin %	20.8%	3.3%	14.4%	11.7%	7.5%	3.9%	19.3%	13.2%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BHC Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$24.8B	$26.3B	$26.5B	$27.4B	$25.7B	$29.2B	$31.2B	$33.9B	$27.4B	$37.5B	$43.5B	$49.0B	$26.4B	$28.0B	$17.9B	$13.1B	$10.8B	$2.1B	$1.6B	$1.8B	$2.2B
Cash & Cash Equivalents	$1.8B	$1.3B	$1.2B	$947M	$564M	$582M	$605M	$3.2B	$721M	$720M	$542M	$597M	$323M	$600M	$916M	$164M	$394M	$114M	$318M	$434M	$834M
Total Liabilities	$25.6B	$25.9B	$26.8B	$27.4B	$25.4B	$29.2B	$30.6B	$32.7B	$29.7B	$31.6B	$40.3B	$42.9B	$20.9B	$22.7B	$14.2B	$9.2B	$5.9B	$705M	$422M	$484M	$890M
Total Debt (Short + Long-Term)	$20.8B	$20.9B	$21.7B	$22.4B	$20.8B	$22.7B	$24.0B	$25.9B	$24.3B	$25.4B	$29.8B	$31.1B	$15.3B	$17.4B	$11.0B	$6.7B	$3.6B	$326M	$118M	$267M	$412M
Total Shareholders' Equity	($1.8B)	($553M)	($1.3B)	($1.0B)	($692M)	($34M)	$605M	$1.1B	$2.7B	$5.8B	$3.2B	$5.9B	$5.3B	$5.1B	$3.7B	$3.9B	$4.9B	$1.4B	$1.2B	$1.3B	$1.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BHC viewer.

Other Companies in DRUG MANUFACTURERS - SPECIALTY & GENERIC

HCM · HUTCHMED DRC — $2 billion
BCRX · BioCryst Pharmaceuticals Inc — $2 billion
TRLV · Trulieve Cannabis Corp. — $2 billion
PBH · Prestige Brand Holdings Inc — $2 billion
ALVO · Alvotech — $2 billion
PRGO · Perrigo Company PLC — $2 billion
ANIP · ANI Pharmaceuticals Inc — $2 billion
ETON · Eton Pharmaceuticals Inc — $2 billion

← BHAV All “B” companies BHDG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.